PMH10 COST-EFFECTIVINESS ANALYSIS OF LONG ACTING MICROSPHERES OF RISPERIDONE (RISPERDAL CONSTA) IN THE TREATMENT OF SCHIZOPHRENIA IN MEXICO
May 1, 2007, 00:00 AM
10.1016/S1098-3015(10)68763-3
https://www.valueinhealthjournal.com/article/S1098-3015(10)68763-3/fulltext
Section Title :
Section Order :
546
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)68763-3&doi=10.1016/S1098-3015(10)68763-3